Karsten Denner
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
-
- Hormonal Regulation and Hypertension
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
-
- Hormonal Regulation and Hypertension 5
- Co-authors
- Rita Bernhardt (6 shared papers)Johannes Doehmer (2 shared papers)Arne Östman (2 shared papers)Enrico Jandt (2 shared papers)Marina V. Kovalenko (2 shared papers)Thomas Backensfeld (1 shared paper)Anne Christiansen (1 shared paper)Werner Weitschies (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Endocrine Research (2 papers)Drug Metabolism and Disposition (2 papers)European Journal of Biochemistry (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Karsten Denner
21 papers receiving 942 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 187
- Endocrinology, Diabetes and Metabolism 217
- Pharmaceutical Science 56
- Oncology 200
- Molecular Biology 478
Countries citing papers authored by Karsten Denner
This map shows the geographic impact of Karsten Denner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Denner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Denner more than expected).
Fields of papers citing papers by Karsten Denner
This network shows the impact of papers produced by Karsten Denner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Denner. The network helps show where Karsten Denner may publish in the future.
Co-authors
The 25 scholars most cited alongside Karsten Denner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 163 | |
| 2 | 2000 | 125 | |
| 3 | 2019 | 81 | |
| 4 | 2011 | 76 | |
| 5 | 1995 | 67 | |
| 6 | 2021 | 64 | |
| 7 | 2006 | 64 | |
| 8 | 2020 | 63 | |
| 9 | 1998 | 59 | |
| 10 | 1995 | 41 | |
| 11 | 2003 | 40 | |
| 12 | 1995 | 38 | |
| 13 | 2024 | 25 | |
| 14 | 1995 | 22 | |
| 15 | 1998 | 15 | |
| 16 | 2021 | 11 | |
| 17 | 1993 | 8 | |
| 18 | 2001 | 6 | |
| 19 | 2024 | 4 | |
| 20 | [Clinical study on the application of demineralized bone matrix (DBM) in surgical orthodontics]. | 1990 | 3 |
About Karsten Denner
Karsten Denner is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Urology and Immunology and Allergy, having authored 21 papers that have together received 976 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Hormonal Regulation and Hypertension (5 papers), Cancer therapeutics and mechanisms (2 papers), Pharmacological Effects and Assays (2 papers), Estrogen and related hormone effects (2 papers), Bone Tissue Engineering Materials (2 papers), Cell Adhesion Molecules Research (2 papers) and Steroid Chemistry and Biochemistry (2 papers). The work is most often cited by research in Pharmacology (187 citations), Endocrinology, Diabetes and Metabolism (217 citations), Pharmaceutical Science (56 citations), Oncology (200 citations) and Molecular Biology (478 citations). Karsten Denner has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Rita Bernhardt, Johannes Doehmer, Arne Östman, Enrico Jandt, Marina V. Kovalenko, Thomas Backensfeld, Anne Christiansen, Werner Weitschies, Frank D. Böhmer and Ramon Vilella. Their work appears in journals such as Journal of Medicinal Chemistry, Endocrine Research, Drug Metabolism and Disposition, European Journal of Biochemistry and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.